blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0547149

EP0547149 - INHIBITION OF HERPESVIRIDAE INFECTION BY ANTISENSE OLIGONUCLEOTIDES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  10.07.1998
Database last updated on 12.07.2024
Most recent event   Tooltip10.07.1998Application deemed to be withdrawnpublished on 26.08.1998 [1998/35]
Applicant(s)For all designated states
GENTA INCORPORATED
3550 General Atomics
San Diego, CA 92121 / US
[1993/25]
Inventor(s)01 / ROIZMAN, Bernard
5555 South Everett
Chicago, IL 60637 / US
02 / MAXWELL, Kameron, W.
P.O. Box 3736
Rancho Sante Fe, CA 92067 / US
[1993/25]
Representative(s)Hansen, Bernd, et al
Hoffmann Eitle Patent- und Rechtsanwälte Postfach 81 04 20
81904 München / DE
[N/P]
Former [1998/03]Hansen, Bernd, Dr. Dipl.-Chem., et al
Hoffmann Eitle, Patent- und Rechtsanwälte, Postfach 81 04 20
81904 München / DE
Former [1993/25]Hansen, Bernd, Dr.rer.nat., et al
Hoffmann, Eitle & Partner Patentanwälte Postfach 81 04 20
D-81904 München / DE
Application number, filing date91916956.513.08.1991
[1993/25]
WO1991US05756
Priority number, dateUS1990056850115.08.1990         Original published format: US 568501
[1993/25]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO9203051
Date:05.03.1992
[1992/06]
Type: A1 Application with search report 
No.:EP0547149
Date:23.06.1993
Language:EN
The application published by WIPO in one of the EPO official languages on 05.03.1992 takes the place of the publication of the European patent application.
[1993/25]
Search report(s)International search report - published on:US02.04.1992
(Supplementary) European search report - dispatched on:EP15.07.1993
ClassificationIPC:C12N15/11, A61K31/70, C07H21/00
[1993/31]
CPC:
A61K31/70 (EP,KR); A61P31/12 (EP); A61P31/22 (EP);
C12N15/1133 (EP); C12N2310/321 (EP); C12N2310/3521 (EP)
Former IPC [1993/25]A01N43/04, A61K31/70, C07H15/12, C07H17/00
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1993/25]
TitleGerman:INHIBIERUNG DER HERPESVIRIDAE-INFEKTION DURCH ANTISENSE-OLIGONUKLEOTIDE[1993/25]
English:INHIBITION OF HERPESVIRIDAE INFECTION BY ANTISENSE OLIGONUCLEOTIDES[1993/25]
French:INHIBITION DE L'INFECTION PROVOQUEE PAR LE VIRUS DE L'HERPES, A L'AIDE D'OLIGONUCLEOTIDES NON CODANTS[1993/25]
Entry into regional phase15.02.1993National basic fee paid 
15.02.1993Search fee paid 
15.02.1993Designation fee(s) paid 
15.02.1993Examination fee paid 
Examination procedure12.03.1992Request for preliminary examination filed
International Preliminary Examining Authority: DE
15.02.1993Examination requested  [1993/25]
21.08.1995Despatch of a communication from the examining division (Time limit: M06)
10.06.1996Reply to a communication from the examining division
22.08.1997Despatch of a communication from the examining division (Time limit: M01)
23.08.1997Reply to a communication from the examining division
04.11.1997Despatch of a communication from the examining division (Time limit: M04)
03.03.1998Application deemed to be withdrawn, date of legal effect  [1998/35]
01.04.1998Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [1998/35]
Request for further processing for:10.06.1996Request for further processing filed
10.06.1996Full payment received (date of receipt of payment)
Request granted
24.06.1996Decision despatched
Fees paidRenewal fee
28.06.1993Renewal fee patent year 03
08.08.1994Renewal fee patent year 04
11.08.1995Renewal fee patent year 05
05.08.1996Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.08.199707   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]GB2148302  (AKIRA KAJI);
 [E]WO9112811  (ISIS PHARMACEUTICALS INC [US]);
 [E]WO9205284  (UNIV MARYLAND [US], et al)
 [X]  - JOURNAL OF BIOLOGICAL CHEMISTRY vol. 264, no. 19, 5 July 1989, BALTIMORE, MD US pages 11521 - 11526 GAO, W. ET AL. 'EFFECT OF PHOSPHOROTHIOATE HOMO- OLIGODEOXYNUCLEOTIDES ON HERPES SIMPLEX VIRUS TYPE 2-INDUCED DNA POLYMERASE'
 [X]  - PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA vol. 83, May 1986, WASHINGTON US pages 2787 - 2791 SMITH, C.C. ET AL. 'Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5'
International search[X]US4689320  (KAJI AKIRA [JP])
 [X]  - Journal of General Virology, Volume 69, issued 1988, D.J. McGEOCH et al., "The Complete DNA Sequences of the Long Unique Region in the Genome of Herpes Simplex Virus Type 1", pages 1531-1574, see Figures 1 and 2, and Table 2.
 [X]  - Journal of General Virology, Volume 65, issued 1984, J.L. WHITTON et al., "The Junction between the Repetitive and the Short Unique Sequences of the Herpes Simplex Genome are Determined by the Polypeptide Coding Regions of Two Spliced Immediate-Early mRNAs", pages 451-466, see page 451.
 [X]  - Journal of General Virology, Volume 67, issued 1986, A.J. DAVIDSON et al., "The Complete DNA Sequence of Varicella-Zoster Virus", pages 1759-1816, see Figure 2 and Table 1.
 [X]  - Nature, Volume 310, issued 19 July 1984, R. BAER et al., "DNA Sequence and Expression of the B95-8 Epstein-Barr Virus Genome", pages 207-211, see Figure 1 and Table 1.
 [X]  - Proceedings National Academy of Sciences, Volume 86, issued September 1989, M. KULKA et al., "Site Specificity of the Inhibitory".
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.